Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder

BACKGROUND: Methylphenidate is among the most prescribed medications for treating attention-deficit/hyperactivity disorder (ADHD). However, nearly half of pediatric patients with ADHD do not respond to methylphenidate treatment. Pharmacogenetic testing can aid in identifying patients for whom methyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hain, Daniel T., Al Habbab, Talal, Cogan, Elizabeth S., Johnson, Holly L., Law, Rebecca A., Lewis, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Archival Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616268/
https://www.ncbi.nlm.nih.gov/pubmed/36325160
http://dx.doi.org/10.1016/j.bpsgos.2021.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616268/
https://www.ncbi.nlm.nih.gov/pubmed/36325160
http://dx.doi.org/10.1016/j.bpsgos.2021.07.009

Ejemplares similares